why did the fda ban tirzepatide U.S. Food and Drug Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York FDA says the tirzepatide weight-loss

doi: 10.3945/jn.109.104638 100 PengLLiZ-RGreenRSHolzmanrIRLinJ

Flexibility: Can be taken at any time of day, with or without food

Thus, therapeutic interventions targeting neurovascular health in the context of metabolic syndrome may require a combined approach, emphasizing the pharmacological activation of GLP-1 receptors and dietary modification to achieve optimal results in treating and preventing neurodegenerative and metabolic dysfunctions

It's investigational and not approved by the TGA (Australia's medicines regulator), the US FDA, the European EMA, or any other regulator, for any use

Semaglutide is a GLP-1 receptor agonist that helps you feel fuller faster, eat less, and maintain healthy blood sugar

In mice, a 10-day treatment markedly improved systemic lipid metabolism disrupted by high-fat diet, whereas a 20-day treatment reversed these beneficial effects (Wang et al., 2022)